Bearish
Prestige Consumer Healthcare Inc. (NYSE:PBH) has an average "Hold" recommendation from analysts, with a consensus 12-month price target of $70.75. The...
Prestige Consumer Healthcare Inc.'s CFO & COO, Christine Sacco, received stock awards totaling 11,976 shares from vested performance stock units and a...
Prestige Consumer Healthcare executive William P'Pool received equity compensation awards, including the settlement of 4,187 performance stock units a...
Prestige Consumer Healthcare Inc.'s CEO, Ronald M. Lombardi, received 19,662 shares from vested performance stock units and a new grant of 31,468 Rest...